Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss

Launched by RODOLFO ALEJANDRO · Dec 3, 2013

Keywords

ClinConnect Summary

This clinical trial is looking at patients who have received an islet transplant and have experienced complete loss of the transplant. Islet transplants are procedures where insulin-producing cells from a donor pancreas are placed into a person with Type 1 Diabetes to help control their blood sugar levels. The study aims to better understand the health and well-being of these patients after the transplant has failed.

To participate in this trial, individuals must have a history of at least one islet transplant without receiving any other organ transplants. The trial is open to men and women aged 18 to 75. Participants will be asked to provide written consent and follow the study's procedures. It's important to note that those with a history of other organ transplants or who are unable to understand and comply with the study requirements cannot join. Throughout the study, participants can expect regular check-ins and monitoring as researchers gather information to improve future islet transplant outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. History of at least one islet alone transplant (ie islet transplant in the absence of any other organ transplant).
• Exclusion Criteria:
• • 1. Inability to provide written informed consent.
• • 2. Mentally unstable and/or unable to comply with the procedures of the study protocol.
• • 3. History of any solid organ transplant.